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Purpose of this study was to characterize retinal disease in Usher syndrome using fundus autoﬂuores-
cence and optical coherence tomography. Study included 54 patients (26 male, 28 female) aged 7–
70 years. There were 18 (33%) USH1 and 36 (67%) USH2 patients. 49/52 (94%) patients were found to
carry at least one mutation in Usher genes. Ophthalmological examination included assessment of Snel-
len visual acuity, color vision with Ishihara tables, Goldmann visual ﬁelds (targets II/1–4 and V/4), micro-
perimetry, fundus autoﬂuorescence imaging and optical coherence tomography. Average age at disease
onset (nyctalopia) was signiﬁcantly lower in USH1 than USH2 patients (average 9 vs. 17 years, respec-
tively; p < 0.01); however no signiﬁcant differences were found regarding type of autoﬂuorescence pat-
terns, frequency of foveal lesions and CME, rate of disease progression and age at legal blindness. All
representative eyes had abnormal fundus autoﬂuorescence of either hyperautoﬂuorescent ring (55%),
hyperautoﬂuorescent foveal patch (35%) or foveal atrophy (10%). Disease duration of more than 30 years
was associated with a high incidence of abnormal central fundus autoﬂuorescence (patch or atrophy) and
visual acuity loss.
 2012 Elsevier Ltd. All rights reserved.1. Introduction is rare and characterized late onset progressive hearing lossUsher syndrome is a group of recessively inherited diseases,
characterized by a combination of retinitis pigmentosa (RP) and
sensorineural hearing loss. It has a prevalence of 3-6/100.000
(Millan et al., 2011) and represents 18% of all RP (Boughman,
Vernon, & Shaver, 1983). Nine causative genes have been identiﬁed
and three clinical types are known based on severity of hearing
loss. Usher type 1 (USH1; MYO7A, CDH23, PCDH15, USH1C and
USH1G genes) is characterized by severe congenital hearing loss
while Usher type 2 (USH2; USH2A, GPR98 and DFNB31 genes) is
characterized by moderate congenital hearing loss (Cohen,
Bitner-Glindzicz, & Luxon, 2007). Usher type 3 (USH3; USH3A gene)ll rights reserved.
, optical coherence tomogra-
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), damjan.glavac@mf.uni-lj.si
christine.petit@pasteur.fr (C.(Saihan et al., 2009). Among all Usher genes, the three most
commonly affected are USH2A (36–59%), MYO7A (10–18%) and
PCDH15 (4–6%) (Bonnet & El-Amraoui, 2011). Usher proteins were
found to be integrated into a network in photoreceptor ciliary re-
gion, that could explain the common retinal phenotype (Lefevre
et al., 2008; Maerker et al., 2008; Williams, 2008). Early histopath-
ologic changes in RP are shortening of rod outer segments followed
by rod cell death leading to nyctalopia (Milam, Li, & Fariss, 1998).
With advancement, the retinal degeneration gives rise to a
characteristic ring-shaped scotoma in the mid-periphery, which
can expand to the periphery and macula. As the disease progresses,
the cone photoreceptors also degenerate leading to loss of central
vision (Milam, Li, & Fariss, 1998; van Soest et al., 1999). Fundus
autoﬂuorescence imaging (FAF) and optical coherence tomography
(OCT) are used for morphological assessment of photoreceptors in
the macular area (Mitamura et al., 2012). Various patterns of
abnormal FAF have been reported in RP patients. Hyperautoﬂuo-
rescent ring can be seen in up to 60% of patients (Popovic, Jarc-
Vidmar, & Hawlina, 2005; Robson et al., 2003) while central
hyperautoﬂuorescence was observed in 18% (Murakami et al.,
2008). It is unclear whether any differences exist in retinal disease
between different Usher types or genotypes. The most consistent
A. Fakin et al. / Vision Research 75 (2012) 60–70 61difference that is found is earlier onset of night blindness in USH1
than in USH2 (Tsilou et al., 2002). More severe form of retinitis
pigmentosa in USH1 was reported by some authors (Edwards
et al., 1998; Fishman et al., 1995; Hope et al., 1997; Piazza et al.,
1986), however others did not share those ﬁndings (Kimberling
et al., 1989; Seeliger et al., 1999; Tsilou et al., 2002).
The main aims of the study are to characterize the natural
course of macular involvement in Usher syndrome using fundus
autoﬂuorescence and to compare FAF and OCT phenotypes associ-
ated with USH1 and USH2 genotypes.1,0
0,8
0,6
0,4
0,2
0,0
Fit line for Total
USH2
USH1
Usher typeA
Pearson’s correlation
r = - 0.52
p < 0.001
Vi
su
al
 a
cu
ity2. Material and methods
2.1. Patients and study design
This prospective cross-sectional study included 54 patients
with Usher syndrome (26 male, 28 female) aged from 7–70 years
(average 44 ± 15). Six pairs of patients were siblings. Diagnosis of
RP was based on nyctalopia, visual ﬁeld constriction, pigmentary
retinal changes, full-ﬁeld scotopic and photopic electroretinogra-
phy and genetic data where available. All patients had sensorineu-
ral hearing loss previously conﬁrmed by audiometry.
Ophthalmological examination included assessment of Snellen vi-
sual acuity (VA), color vision with Ishihara tables, Goldmann visual
ﬁelds (targets II/1–4 and V/4), microperimetry, fundus autoﬂuores-
cence imaging (FAF) and optical coherence tomography (OCT). Eyes
with better quality of FAF and OCT images were chosen as repre-
sentative eyes. Patients were asked about age when they ﬁrst no-
ticed night vision problems (nyctalopia). This age was used as
disease onset in our study. Disease duration was calculated as time
between onset of nyctalopia and examination date.
Molecular diagnosis was performed in 52 patients by sequenc-
ing of all exons and ﬂanking intronic regions of nine known Usher
genes. Statistical analysis was performed using PASW statistical
software (PASW 18.0; PASW Inc., Chicago, IL). Study was approved
by Slovenian Ethics Committee for Research in Medicine and all re-
search procedures have been carried out in accordance with The
Code of Ethics of the World Medical Association (Declaration of
Helsinki) for experiments involving humans. Informed consent
was obtained from all subjects.Age (years)
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Fig. 1. Visual acuity in association with age (A) or disease duration (B) in Usher
patients (N = 43). Patients with media opacities or large CME were excluded.
Correlation was stronger between visual acuity and disease duration (r = 0.65)
than between visual acuity and age (r = 0.52). It was signiﬁcant in both cases
(p < 0.001, Pearson’s correlation).2.2. Fundus autoﬂuorescence and spectral-domain optical coherence
tomography
Fundus autoﬂuorescence imaging of 30 ﬁeld of view and 8-mm
Spectral-domain OCT scan through the fovea were performed
simultaneously with a confocal scanning laser ophthalmoscope
(OCT-SLO Spectralis, Heidelberg Engineering, Dossenheim,Germany)
after pupil dilation with topical 1% Tropicamide. Patterns of FAF
were determined in 51/54 patients. In three patients this was not
possible due to imaging difﬁculties or severe cystoid macular
edema (CME). Measurements of structures on FAF and OCT were
performed using Spectralis software withmicrometer caliper. Tem-
poral horizontal radius of the hyperautoﬂuorescent ring (distance
from fovea to inner and outer border) or patch was measured on
FAF image. Distance from the fovea along the horizontal midline
to the location of disappearance of inner segment ellipsoid (ISe)
junction and external limiting membrane (ELM) were measured
on OCT. Thicknesses of the outer nuclear layer (from upper border
of ELM/ONL to the upper border of OPL/INL) was measured in the
fovea. Measurements of FAF structures, ELM and ISe were rounded
to 0,01 mm to compensate for measurement error. Conversion of
1 mmof retina to 3.5 of visual ﬁeld was used. Longitudinal changes
in FAF were evaluated in 18 patients who have previously
undertaken autoﬂuorescence imaging. Visual function and retinalstructure were compared between different FAF patterns in pa-
tients without media opacities or large CME (N = 43).
2.3. Microperimetry
Static microperimetry was performed with the Nidek MP1 (Ni-
dek Technologies, Padua, Italy) after pupil dilation with topical 1%
tropicamide. Minimum of 12 stimuli in the central 8 of retina
were used. Stimuli of the size of Goldmann III target appeared
for 200 ms and changed intensity in 4–2 strategy. Average retinal
sensitivity of central 12 stimuli (8 of retina) was calculated using
MP1 software. Additionally, kinetic microperimetry using 0 dB
stimulus, size Goldmann III, moving in eight directions from 10
to the foveal center with velocity of 2.4/s was performed on 10 pa-
tients with hyperautoﬂuorescent rings.
3. Results
3.1. Clinical data
There were 18 (33%) USH1 patients with average age of
33 ± 16 years and 36 (67%) USH2 patients with average age of
49 ± 12 years. 49/52 (94%) analyzed patients were found to carry
at least one mutation in Usher genes. Among those, there were
FAF pattern
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Fig. 2. Fundus autoﬂuorescence of 51 patients with different types of Usher syndrome. Eyes with better image quality are presented. Three patients were excluded due to
large CME or imaging difﬁculties. FAF patterns were divided into categories of large ring (radiusP 3), small ring (radius < 3), foveal patch and atrophy. Genotyped patients
are marked with capital letters (M =MYO7A, P = PCDH15, C = CDH23, 1C = USH1C, U = USH2A, V = VLGR1, 1G = USH1G). Below is a box plot graph showing disease duration in
different FAF categories.
Table 1
Frequency of FAF patterns of ring, patch and atrophy in Usher patients with known genotypes. All three patterns were observed in the three most commonly affected genes
(USH2A, MYO7A and PCDH15). In one USH2A patient and one MYO7A patient pattern was unable to be determined due to cystoid macular edema and imaging difﬁculties,
respectively. FAF = fundus autoﬂuorescence.
USH type USH2 USH1
Genotype USH2A MYO7A PCDH15 CDH23 VLGR1 USH1C USH1G
N 29 11 4 2 1 1 1
Avg. age (years) 50 33 40 20 29 23 48
Avg. age at onset (years) 17 9 10 4 4 19 2
Avg. disease duration (years) 33 24 30 17 25 4 46
FAF pattern frequency
Ring (percent, N) 48% (14) 46% (5) 50% (2) 50% (1) 100% (1)
Patch (percent, N) 31% (9) 36% (4) 25% (1) 50% (1)
Atrophy (percent, N) 3% (1) 9% (1) 25% (1) 100% (1) 100% (1)
Ring on one eye and patch on the other 10% (3)
Patch on one eye and atrophy on the other 4% (1)
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Fig. 3. (A) Inner ring radius in association with disease duration (N = 24). Four
patients were excluded because of difﬁculties in FAF analysis due to CME (3) or
cataract (1). (B) Spaghetti graph showing decrease of inner ring radius over the
years in 13 patients with Usher syndrome. Dashed lines represent USH 1 patients.
(C) Sequential fundus autoﬂuorescence imaging of two patients showing ring
constriction (up) and progression from patch to atrophy (bottom). Age at the time
of examination is marked on FAF images.
A. Fakin et al. / Vision Research 75 (2012) 60–70 6359% (29) USH2A, 22% (11)MYO7A, 8% (4) PCDH15, 4% (2) CDH23, 2%
(1) VLGR1, 2% (1) USH1C and 2% (1) USH1G patients. Average age at
disease onset (nyctalopia) was 14 years (range 1–39) and was sig-
niﬁcantly lower in USH1 patients (average 9 years) than USH2 pa-
tients (average 17 years), p < 0.01. Average disease duration was 30
years (range 2–60 years). VA on the better eye ranged from 1.0 (20/
20) to light perception. Correlation between visual acuity and dis-
ease duration was stronger than correlation between visual acuity
and age. It was signiﬁcant in both cases (Fig. 1). VA less than <0.05
(20/400) on the better eye, classiﬁed as blindness by World Health
Organization, was found in 9/54 (17%) patients (3 USH1, 6 USH2).
They were 60 ± 8 years old with 45 ± 9 years of disease duration.
Age and disease duration of those patients was not signiﬁcantly
different between USH1 and USH2 patients. There were three chil-
dren with Usher type 1, ages 7, 9 and 12 years. All three children
had a hyperautoﬂuorescent ring and CME at the time of
presentation.
3.2. Fundus autoﬂuorescence patterns
All patients had abnormal fundus autoﬂuorescence. Three main
patterns were recognized, namely hyperautoﬂuorescent ring,
hyperautoﬂuorescent foveal patch and abnormal central hypoauto-
ﬂuorescence (atrophy). Ring was further divided into two subcate-
gories (large and small) in respect to radius of inner ring border
(Fig. 2). All FAF patterns could be seen in USH1 and USH2 patients
and also in patients with the three most commonly affected genes
(USH2A, MYO7A and PCDH15) (Table 1 and Fig. 2). Asymmetric FAF
was observed in 5/51 (10%) patients. One USH1C patient had rings
with large difference in size, three USH2A patients had a combina-
tion of unilateral ring and unilateral patch (two are shown in
Fig. 4E) and one USH2A patient had a combination of unilateral
patch and unilateral central hypoautoﬂuorescence.
3.2.1. Hyperautoﬂuorescent ring
Hyperautoﬂuorescent ring was seen in 28/51 (55%) representa-
tive eyes. 22/28 (79%) of rings were surrounded with a ring of de-
creased autoﬂuorescence (Fig. 2) which in some cases correlated
with RPE atrophy on OCT. All rings were located inside vascular ar-
cades. Location of inner and outer ring border could be determined
in 24/28 patients; in four patients this was not possible due to cat-
aract and/or CME. Internal radii ranged from 0.21 to 2.77 mm and
external radii from 0.52 to 3.32 mm. Average ring width was
0.56 ± 0.32 mm. Inner ring radiuswas smaller in patientswith long-
er disease duration (Fig. 3A). Average visual acuity in patients with-
out media opacities or CME (N = 20) was 0.8 ± 0.2 (range, 0.3–1.0).
3.2.2. Hyperautoﬂuorescent foveal patch
Hyperautoﬂuorescent foveal patch was seen in 18/51 (35%)
eyes. It was surrounded by a ring of decreased or absent autoﬂuo-
rescence (Fig. 2) which in 17/18 patients correlated with RPE atro-
phy on OCT (examples in Fig. 6, third and fourth column). Presence
of patch was associated with longer disease duration (average
37 years) than presence of ring (average 23 years) (t-test,
p = 0.001). Radius of patch ranged from 0.22 to 0.86 mm (average
0.52 mm) and did not correlate with disease duration (Pearson’s
correlation, r = 0.16, p = 0.56). Average visual acuity in patients
without media opacities or CME was 0.2 ± 0.2 (range, 0.001–0.6).
3.2.3. Central hypoautoﬂuorescence (atrophy)
Abnormal foveal hypoautoﬂuorescence (atrophy) was seen in 5/
51 (10%) eyes. It was surrounded with variable amount of residual
perifoveal autoﬂuorescence (Fig. 2). VA ranged from 0.15 to no
light perception (average 0.04 ± 0.06).
Anophthalmos
A USH2A B USH2A
C MYO7A D USH2, not genotyped
E USH 2A F USH2A
Fig. 4. Fundus autoﬂuorescence in six pairs of siblings (A–F) with Usher syndrome. Speciﬁc details appeared similar between siblings, such as small dark spots on the outer
ring border (A), large spots of atrophy (E and F) and peripapillary atrophy (F). Autoﬂuorescence pattern on the periphery was also similar in all pairs. Differences between
siblings included presence of cystoid macular edema (B bottom and D up) and optic disc drusen (D up and C bottom). Bottom sibling in pair B has had left eye enucleated due
to neovascular glaucoma.
64 A. Fakin et al. / Vision Research 75 (2012) 60–703.3. Fundus autoﬂuorescence in siblings with Usher syndrome
Six pairs of siblings with Usher syndrome were included in this
study (Fig. 4). Because siblings have presumably the samemutations
(conﬁrmed inﬁvepairs),weanalyzed their FAFpatterns forgenotype
speciﬁccharacteristics. Fourpairspresentedwithmatchingpatterns,
including bilateral ring (Fig. 4A and B), bilateral patch (Fig. 4F) or
combination of unilateral ring and unilateral patch (Fig. 4E). Two
pairs presented with different FAF patterns (Fig. 4C and D), possibly
as a result of different disease duration (pair C 14 and27 years, pairD
46 and 54 years). Common characteristics included similar patternof peripheral autoﬂuorescence, small dark spots on the outer ring
border, large spots of atrophy and/or peripapillary atrophy. Differ-
ences thatwere observedbetween siblings included presence of cys-
toid macular edema and optic disc drusen (Fig. 4).
3.4. Visual ﬁeld in relation to fundus autoﬂuorescence
Residual visual ﬁeld (tested with Goldmann V/5 target) was de-
tected in average of 7 eccentrically to the outer ring or patch bor-
der. Goldmann II/4 target was detected eccentrically to the outer
ring/patch border in all patients with large rings, 83% of patients
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Fig. 5. Visual ﬁeld in relation to fundus autoﬂuorescence. (A) In majority of
patients, visual ﬁeld measured with Goldmann II/4 stimulus distended over larger
area than the ring or patch on FAF. (B) Eccentricity of visual ﬁeld from outer ring/
patch border in association with disease duration. Border of preserved visual ﬁeld
was closer to the ring/patch in patients with long-standing disease. (C) Comparison
of microperimetry and Goldmann perimetry in relation to ring radius. Goldmann II/
4 target was usually detected further away than the highest intensity stimulus
(0 dB) on microperimetry. Dashed line represents a situation where testing
stimulus is detected exactly on the outer border of ring/patch (radius of visual
ﬁeld equals radius of autoﬂuorescence).
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and 2 eccentrically to border of hyperautoﬂuorescence) (Fig. 5A).Eccentricity of II/4 visual ﬁeld in relation to AF border decreased
with disease duration (Pearson’s correlation, r = 0.4, p = 0.01)
(Fig. 5B). Goldmann II/1 target was detected by all patients with
large rings and 58% of patients with small rings, in average 1 inter-
nally to the inner ring border. Ten patients with hyperautoﬂuores-
cent rings additionally underwent kinetic microperimetry with
stimulus of highest intensity (0 dB). In those patients temporal ra-
dii of visual ﬁelds measured by Goldmann perimetry (II/4 and II/3)
and microperimetry were compared. Goldmann visual ﬁeld using
II/4 stimulus was in average 2.4 ± 2.3 larger than MP visual ﬁeld
(Fig. 5C). Goldmann visual ﬁeld using II/3 stimulus was in average
0.4 ± 1.3 smaller than MP visual ﬁeld.3.5. Optical coherence tomography ﬁndings
In all eyes with rings, OCT revealed preserved ELM and ISe
across the fovea. In eyes with patch, foveal ELM was seen in all
cases and remains of ISe were found in 5/18 (28%) cases (average
radius 0.21 mm). Eyes with patches that had remains of ISe had
signiﬁcantly better VA than eyes without it (average 0.5 vs. 0.1;
p < 0.001). Foveal ONL thickness was not signiﬁcantly different be-
tween the two groups (average 55 vs. 56 lm; p = 0.9). In eyes with
central hypoautoﬂuorescence, OCT revealed severely disorganized
retinal structure with areas of RPE atrophy. Neither ISe nor ELM
could be recognized (Fig 6, last column). In eyes with preserved
ISe (all eyes with ring and 5/18 eyes with patch), visual acuity
and color vision were low when ISe loss encroached on fovea (ra-
dius 500 lm), regardless of FAF pattern of ring or patch (Fig. 7).3.5.1. Correlations between structures on FAF and OCT
In aligned photos of FAF and OCT we observed spatial correla-
tions between inner/outer ring borders and ISe/ELM disruption. In-
ner ring border was located at approximately the same location as
ISe disruption and outer ring border was located are approximately
the same location as ELM disruption (point where ELM disap-
peared or fused with RPE) (Fig. 8). We were interested whether
the correlations were exact; therefore we calculated average dis-
tances between corresponding structures on FAF and OCT. In aver-
age, distance between inner ring border and ISe disruption was
0.13 ± 0.21 mm (range, 0.01 to 0.65 mm; inner ring border was
closer to the fovea). Out of the four cases with the largest differ-
ence (>0.30 mm), one had large CME (Fig. 8D), one had microcysts
and two were without CME. Average difference between outer ring
border and ELM disruption was 0.01 ± 0.16 mm (range, 0.44 to
0.29 mm; outer ring border was located closer to the fovea than
ELM loss). In eyes with patch, there was a spatial correlation be-
tween patch border and horizontal span of ELM (Fig. 6, third and
fourth column; Fig. 8B). In average, ELM loss appeared 0.04 mm
closer to the fovea than patch border.3.5.2. Cystoid macular edema
Cystic changes on OCT were seen in at least one eye of 56% (30/
54) of patients. They were present in 56% (10/18) of USH1 and 56%
(20/36) of USH2 patients. Out of patients with CME, 23% (7/30) had
large CME, 57% (17/30) mild CME and 20% (6/30) had micro cystic
changes on the more affected eye. Cysts were present in INL (60%,
18), INL and ONL (33%, 10) or OPL (7%, 2). Location or frequency of
CME was not dependent on USH type.3.6. Progression of disease in Usher syndrome
Disease progression in the retina was studied with longitudinal
and cross-sectional analysis. Visual function and retinal structure
were strongly associated with disease duration (Fig. 9).
Fig. 6. Examples of Usher patients with different FAF patterns. Fundus photographs, optical coherence tomography and autoﬂuorescence overlaid with microperimetry are
shown. White lines show the point of ISe loss and dashed white lines show point of ELM loss. Below is a schematic representation of proposed disease progression.
FAF = fundus autoﬂuorescence, ISe = inner segment ellipsoid, ELM = external limiting membrane.
66 A. Fakin et al. / Vision Research 75 (2012) 60–703.6.1. Longitudinal analysis of fundus autoﬂuorescence
Longitudinal changes were assessed in 18 patients who have
previously undergone FAF imaging.
Thirteen patients (3 USH1, 10 USH2, without large CME) at
baseline imaging presented with hyperautoﬂuorescent ring with
average radius of 1.55 ± 1.19 mm. At follow up (7 ± 2 years), ring
was seen again in all patients with average inner ring radius of
1.15 ± 0.67 mm. None of the patients developed central patch or
hypoautoﬂuorescence. Ring constriction was observed in 12/13 pa-
tients (Fig. 3B). Average rate of ring inner border constriction was
0.06 mm (range, 0.00–0.25 mm) or 4% (range, 0–9%) of starting
radius per year. Outer ring border could be detected in 12/13
patients. Its average rate of constriction was 0.06 mm (0.00–
0.23 mm) or 3% (range, 0–10%) per year. Rate of constriction was
not dependent on USH type. After excluding two patients with
changes in media opacities and one for lack of visual acuity data,
there was a signiﬁcant drop in average visual acuity in this group
(from 0.94 to 0.88, p < 0.01). Out of those patients, four were with-
out CME, three had microcysts and three had mild CME.
Five patients at baseline imaging presented with foveal patch.
In two of them patch remained at follow-up after 5 years with
change in radius from 0.65 to 0.60 and 0.74 to 0.70 mm, respec-
tively. Average rate of patch radius constriction was 0.01 mm or1% per year. Visual acuity in those patients remained unchanged
and was 0.6 in patient with central remains of ISe and 0.015 in pa-
tient with absent ISe. In three patients patch was replaced with
central hypoautoﬂuorescence (atrophy) at follow-up after 6–
9 years (Example in Fig. 3C). Average VA in those patients de-
creased from 0.28 to 0.08.
3.6.2. Cross-sectional analysis of fundus autoﬂuorescence
FAF images were organized into categories of large ring (P3
internal radius), small ring (<3 internal radius), patch and central
hypoautoﬂuorescence (atrophy) and average disease duration was
calculated for different categories. Ring was observed mainly in pa-
tients with up to 30 years of disease (large ring average 13 years,
range 2–26; small ring average 28 years, range 4–60) whereas
patch and atrophy were observed in patients with longer disease
duration (patch average 36 years, range 9–54; atrophy average
44 years, range 25–60) (Fig. 2). Difference in disease duration
was signiﬁcant between patients with small ring and patch and
not signiﬁcant between large and small ring or patch and atrophy
(Table 2). Retinal structure (ONL thickness, ELM radius, ISe radius)
and function (VA, color vision, visual ﬁeld, retinal sensitivity) de-
creased signiﬁcantly in association with FAF changes (Pearson’s
correlation, p < 0.001 for all) (Table 2, examples in Fig. 6). Foveal
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(27%) of USH1 and 4/17 (24%) of USH2 patients with up to 30 years
of disease and in 5/6 (83%) of USH1 and 13/17 (76%) of USH2 pa-
tients with more than 30 years of disease. Frequencies were not
signiﬁcantly different between USH1 and USH2 patients (Fisher’s
exact test, p > 0.5).4. Discussion
This study suggests that Usher syndrome patients have com-
mon morphological stages of retinal disease in the macula that
can be characterized by FAF patterns of ring, patch and foveal atro-
phy. Ring represents early stage of disease with relatively pre-
served central visual function while patch and atrophy represent
advanced disease with moderate to severe loss of vision.
4.1. Fundus autoﬂuorescence abnormalities
Murakami et al. classiﬁed FAF patterns of RP patients including
one Usher patient into patterns of ring, central hyperautoﬂuores-
cence and absence of both. They hypothesized different patterns
could be a result of different pathogenesis or different disease
stages (Murakami et al., 2008). We have also found patterns of ring
and central hyperautoﬂuorescence (patch), however no patients
had absence of both and we also had a group of patients withcentral hypoautoﬂuorescence which they have not described. Dif-
ference in our ﬁndings could be a result of different stages of the
disease or differences between Usher syndrome and nonsyndromic
RP. In a few cases it was difﬁcult to distinguish between ring and
patch on FAF (examples in Fig. 4E). It is possible that those cases
represent intermediary stages between ring and patch pattern,
which could be conﬁrmed with longitudinal FAF imaging. While
it is known that abnormal FAF can be seen in patients with retinitis
pigmentosa, the location of ﬂuorophores in the retina contributing
to hyperautoﬂuorescence is not clear. Recently it has been pro-
posed that photoreceptor cells could be a major source of autoﬂuo-
rescence in pathological states (Sparrow et al., 2010). OCT ﬁndings
in the ring and patch area suggest absence of outer segments in
those areas. We propose that photoreceptor inner segments or cell
bodies could be the location of abnormal bisretinoid accumulation,
possibly contributing to photoreceptor apoptosis (Cottet & Schord-
eret, 2009; Maeda et al., 2008).
4.2. OCT ﬁndings
The hyper-reﬂective band representing ELM appeared to be in-
tact across the foveal area in all eyes with rings or patches and ab-
sent in eyes with central hypoautoﬂuorescence. ELM length
correlated closely with outer ring border and patch border, con-
tributing to the idea that patch is a stage following ring. Central re-
mains of ISe were seen in all patients with rings and showed good
spatial correlation with the area of normal autoﬂuorescence inside
the ring. In patients with patches, ISe was either absent or had ra-
dius shorter than 0.5 mm (foveal radius). Spatial correlation be-
tween AF and OCT structures was not always exact, i.e. inner ring
border was measured in average 0.1 mm closer to the fovea than
ISe loss. An explanation for this could be measurement error, espe-
cially in recognizing the exact location of inner ring border due to
rising signal of autoﬂuorescence from the foveal center towards
the periphery or due to presence of CME (Fig. 8C).
4.3. FAF and OCT in relation to visual function
Hyperautoﬂuorescent ring was associated with relatively pre-
served central visual function, which is in agreement with previous
studies (Popovic, Jarc-Vidmar, & Hawlina, 2005; Robson et al.,
2003, 2004, 2006). Nevertheless some loss of central vision was ob-
served in majority of patients even at this stage. Visual acuity and
color vision were lower in patients with ring radius smaller than 3
and the dimmest (II/1) Goldmann target was often not detected by
those patients (see Section 3.4). Patients with ISe radius smaller
than radius of fovea were most affected (Fig. 7). Similarly, decrease
in VA associated with ring constriction was described in rings
smaller than 0.68 mm (2.5) in radius (Aizawa et al., 2010). These
ﬁndings could be explained by deterioration of retinal structure in-
side the rings that has been described in literature, such as short-
ening of outer segments and ONL thinning in areas of preserved ISe
(Hood et al., 2011) and reduced cone numbers inside the rings
(Greenstein et al. IOVS, 2012; 53: ARVO E-Abstract 4577).
Microperimetry and ﬁne matrix mapping studies have shown
strong spatial correspondence between sensitivity losses and the
internal edge of the ring (Lenassi et al., 2012; Robson et al., 2004,
2012). They have shown that sensitivity is well preserved inside
the ring of hyperautoﬂuorescence and decreases with eccentricity.
We have also found good sensitivity inside the ring and decreased
sensitivity outside the ring using Goldmann perimetry (stimulus II/
1 was detected only inside while II/4 and V/4 were detected out-
side the ring in most patients). Large Goldmann target with high
intensity (V/4) was used to determine how far from the ring any
light stimulus can still be detected. Our results suggest that
although abnormal, there usually is some cone function up to
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of RP retinas have shown that when all rods and most of the cones
are lost, the macula usually retains a monolayer of cone somata
with very short or absent outer segments (Milam, Li, & Fariss,
1998), which might explain this residual cone function.
Hyperautoﬂuorescent foveal patch was seen in patients with
several decades of disease duration and was associated with signif-
icant loss of central visual function and ONL thinning (Table 2),
reﬂecting loss of photoreceptor cells in the fovea. Visual acuity
was relatively preserved only in patients with central remains of
ISe, which might represent a transition from ring to patch.
Abnormal central hypoautoﬂuorescence (foveal atrophy) was seen
in 5 eyes and was associated with the most severe loss of retinal
structure and function. Limitation of the current study is that
scotopic macular function was not examined as all examinations
were performed under photopic conditions and therefore only
function of cones could be evaluated.4.4. Disease progression
Serial FAF imaging of rings in patients with short disease dura-
tion and the presence of central FAF abnormalities in cases with
long-standing disease suggest that rings constrict with time and
may eventually be replaced by central FAF abnormalities (hyper-
autoﬂuorescent patch and atrophy) associated with visual acuity
loss. This is in keeping with published data that demonstrated pro-
gression from a ring to central hyperautoﬂuorescence in a few indi-
viduals (Robson et al., 2011; Wakabayashi et al., 2010).
Additonally, we have observed progression from central hyper-
autoﬂuorescence (patch) to central hypoautoﬂuorescence (atro-
phy) in three patients (example in Fig. 3C).
Average rate of disease progression in the macula was esti-
mated by measuring ring constriction and was 4% per year. This
is in good agreement with two previously published papers. Lima
et al. reported rates of inner border constriction for two patients
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Table 2
Differences in retinal structure and function between patients with large ring, small ring, patch or atrophy. Patients with CME, cataract, macular traction or posterior capsular
opaciﬁcation are excluded. Values which are signiﬁcantly different between each other are marked in bold (ANOVA, LSD post hoc test, p < 0.05). y = Years, ELM = external limiting
membrane, ISe = inner segment ellipsoid, ONL = outer nuclear layer, VA = visual acuity, N/A = not applicable.
FAF pattern Large ring (rP 3) Small ring (r < 3) Patch Atrophy Pearson’s correlation (r, p)
N 8 12 18 5
Age (average, range) 31y (7–58) 37y (23–54) 50y (32–69) 51y (29–69) 0.5, <0.001
Disease duration (average, range) 13y (2–26) 22y (4–33) 37y (9–54) 44y (25–60) 0.7, <0.001
Retinal structure (average, range)
Outer ring border/patch radius 6 (4–12) 4 (2–8) 2 (1–3) N/A 0.8, <0.001
ELM radius 6 (4–10) 4 (2–8) 2 (1–4) N/A 0.8, <0.001
Inner ring border radius 5 (3–10) 2 (1–3) NA N/A 0.7, <0.001
ISe radius 5 (3–9) 2 (1–4) 1 (0–2) N/A 0.8, <0.001
ONL thickness in fovea 114 lm (93–129) 108 lm (63–182) 56 lm (36–88) N/A 0.8, <0.001
Retinal function (average, range)
VA 0.9 (0.5–1.0) 0.7 (0.3–1.0) 0.2 (0.001–0.6) 0.04 (0–0.15) 0.8, <0.001
Number of recognized Ishihara tables 12 (1–15) 6 (0–13) 1 (0–6) 0 (0–1) 0.8, <0.001
II/1 visual ﬁeld radius 3 (1–7) 1 (0–2) N/A N/A 0.8, <0.001
II/4 visual ﬁeld radius 14 (6–25) 7 (2–13) 3 (0–9) 3 (0–6) 0.7, <0.001
Average sensitivity in central 8 13 dB (7–19) 6 dB (1–13) 1 dB (0–7) 0 dB (0–1) 0.8, <0.001
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their data to be 4% per year (Lima et al., 2012). Robson et al.reported inner border constriction in 6/12 Usher patients. Taken
all 12 patients together, their average rate of constriction was cal-
culated at 5% per year (Robson et al., 2011). Reported rates of visual
ﬁeld constriction are somewhat higher (6–9%) (Fishman et al.,
2007; Iannaccone et al., 2004; Sandberg et al., 2008).
4.5. Disease expression in different types of Usher syndrome
The existence of different clinical subtypes of Usher syndrome
based on hearing loss have been known for a long time, however
possible differences in retinal phenotype have been controversial.
Apart from earlier disease onset in USH1 we have not found any
other differences in disease expression. We found the same basic
FAF patterns in USH1 and USH2 patients as well as in all three
the most commonly affected genes (USH2A, MYO7A and PCDH15).
Similarly, Jacobson et al. have not found any differences when
analyzing OCT of MYO7A, PCDH15, USH2A and GPR98 patients
(Jacobson et al., 2008). When separately analyzing patients with
short and long-standing disease, USH1 patients did not have signif-
icantly higher frequency of foveal lesions than USH2. There was
also no signiﬁcant difference between age and disease duration
between USH1 and USH2 patients with legal blindness. We cannot
exclude a possibility that speciﬁc genes or mutations produce vari-
ations of disease expression such as some of the features seen in
our sibling pairs; however this should be conﬁrmed in large groups
of genotype speciﬁc patients with the same disease stage.
4.6. Conclusion
The present study provides an opportunity to increase under-
standing of retinal disease in Usher syndrome. Central vision re-
mained relatively preserved in most Usher patients for up to
three decades after onset of nyctalopia. After three decades the fo-
vea was usually involved, reﬂected by loss of central visual func-
tion. Hyperautoﬂuorescent foveal patch was the hallmark of this
stage. Understanding the natural history of retinal disease in Usher
syndrome will be important in the prospect of clinical trials.
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